Network origin in John K. Whisnant first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Pear Tree Pharmaceuticals, Inc.
 Pear Tree Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pear Tree Pharmaceuticals, Inc. operates as a development stage company with interests in developing prescription products for women. It offers products that treat and prevent diseases, symptoms, and conditions associated with menopause and cancer chemotherapy. The company was founded by Stephen Charles Rocamboli, Fred H. Mermelstein, Janet Chollet and Martin J. Driscoll in July 2007 and is headquartered in Auburndale, MA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John K. Whisnant via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO President | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| QIAGEN N.V. | Medical Specialties | Chairman Founder | |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
RxBazaar, Inc.
 RxBazaar, Inc. Medical DistributorsDistribution Services RxBazaar, Inc. was engaged in distributes pharmaceuticals and medical products. The Company is headquartered in Cincinnati, OH. | Medical Distributors | Director/Board Member | |
| Orion Biomedical Gp LLC | Corporate Officer/Principal | ||
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chairman | |
| FENNEC PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| BIODESIX, INC. | Medical/Nursing Services | Founder | |
NX Development Corp.
 NX Development Corp. Medical SpecialtiesHealth Technology NX Development Corp. operates as a life science company. It develops Gleolan oral solutions which helps in identifying malignant glioma, a type of brain tumor in adult patients. It allows surgeons to visualize brain tumors during surgery. The company was founded by Alan Ezrin and is headquartered in Lexington, KY. | Medical Specialties | Director/Board Member | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Director/Board Member | |
| University of Medicine & Dentistry of New Jersey | College/University | Doctorate Degree | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Director/Board Member | |
PharmaNet, Inc.
 PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Medical Distributors | Director/Board Member | |
| University of Cambridge | College/University | Undergraduate Degree | |
PolaRx Biopharmaceuticals
 PolaRx Biopharmaceuticals Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, PolaRx Biopharmaceuticals is a company that manufactures TriOxide drugs for the treatment of leukemia and other cancers. The company is based in New York, NY. The company was founded by Fred H. Mermelstein, Peter Morgan Kash, Raymond P. Warrell. PolaRx Biopharmaceuticals was acquired by CTI BioPharma Corp., part of Swedish Orphan Biovitrum AB from June 27, 2023 on January 13, 2000 for $17.50 million. | Miscellaneous Commercial Services | Founder | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree | |
| Princeton University | College/University | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Universität zu Köln | College/University | Doctorate Degree Doctorate Degree | |
| University of Vienna | College/University | Corporate Officer/Principal | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
QIAGEN GmbH
 QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
The March Group LLLP
 The March Group LLLP Investment ManagersFinance The March Group LLLP provides investment banking and financial services. Its services include consulting, valuations and private placements. The March Group represents both sellers and buyers in mergers and acquisitions and offers an online listing of companies that are for sale. The company was founded in 1986 and is headquartered in Irving, TX. | Investment Managers | Director/Board Member | |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| Pasteur Mérieux Connaught | Director/Board Member | ||
| Centeon LLC | Director/Board Member | ||
The Rogosin Institute, Inc.
 The Rogosin Institute, Inc. Medical/Nursing ServicesHealth Services The Rogosin Institute, Inc. engages in providing treatment for kidney diseases. The company was founded in 1983 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
| Paramount Capital Investments LLC | Corporate Officer/Principal | ||
| SENSORION | Pharmaceuticals: Major | Chairman | |
| Rhone-Poulenc Pharma GmbH | Director/Board Member | ||
| EUROBIO SCIENTIFIC | Medical Specialties | Director/Board Member | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | General Counsel Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| CHECKMATE PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Founder | |
SanaRx Biotherapeutics, Inc.
 SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA. | Pharmaceuticals: Major | Director/Board Member | |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Biotechnology | Director/Board Member | |
ArkAb SAS
 ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | Medical Specialties | Chairman | |
| Jordan Heart Foundation | Chairman | ||
B Cell Design SAS
 B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Miscellaneous Commercial Services | Chairman | |
| STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 34 |
| France | 5 |
| United Kingdom | 4 |
| Germany | 4 |
| Netherlands | 3 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 4 |
| Distribution Services | 3 |
Operational
| Director/Board Member | 154 |
| Corporate Officer/Principal | 49 |
| Independent Dir/Board Member | 35 |
| Chairman | 33 |
| Founder | 22 |
Most connected contacts
| Insiders | |
|---|---|
| Anthony Evnin | 46 |
| James Edward Thomas | 26 |
| Robert Hugin | 24 |
| Patrick J. Langlois | 23 |
| Stephen Rocamboli | 20 |
| Ken Bate | 19 |
| Robert Cawthorn | 17 |
| Fred H. Mermelstein | 16 |
| Martin Driscoll | 16 |
| Christian Schetter | 12 |
| Susan T. Hager | 11 |
| Ferdinand E. Massari | 10 |
| Robert L. Bratzler | 10 |
| Arthur M. Krieg | 10 |
| Ross Pettit | 9 |
- Stock Market
- Insiders
- John K. Whisnant
- Company connections
